Scanogen
Company

date founded

General

About Company
Scanogen is a molecular diagnostic company.

Industry

Sector :

Subsector :

founded date

01.01.2011

Number of employees

Company Type

For Profit

IPO status

Private

Description

The company has developed a proprietary technology called Single Molecule Tethering (SMOLT) for ultra-sensitive detection of biomolecules, including DNA genotyping and early cancer diagnosis. Scanogen aims to improve healthcare by developing a simple-to-use diagnostic platform using SMOLT. The company has received $9.5 million in NIH grants and is currently focused on point-of-care diagnosis and bloodstream infection detection.
Similar Companies
1000
Genomtec

Genomtec

Genomtec is a biotechnology company that develops mobile technology for molecular diagnostics.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Health Diagnostics

Location

Wrocław, Poland

total rounds

3

total raised

$10.23M
Co-Diagnostics

Co-Diagnostics

Co-Diagnostics is a molecular diagnostics company that develops new technologies to enhance the output of molecular diagnostic tests.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Diagnostics, Health Care

Location

Salt Lake City, UT, USA

total rounds

3

total raised

$6.2M
Nova Satra Dx

Nova Satra Dx

Nova Satra Dx is a molecular diagnostics company that develops innovative blood-based tests for cancer detection.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Diagnostics, Health Care

Location

Singapore

total rounds

2

total raised

$2.5M
Aquila Diagnostic Systems

Aquila Diagnostic Systems

Aquila Diagnostics develops molecular diagnostic testing systems for infectious agents.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical Device

Location

Edmonton, AB, Canada

Financials

Co-Investors

Activity

Recent News
0